Evidence map›Paper›PMID 34884221›Full record

ArticleJournal of clinical medicine2021

Reasons for Utilizing Telemedicine during and after the COVID-19 Pandemic: An Internet-Based International Study.

Arriel Benis, Maxim Banker, David Pinkasovich, Mark Kirin, Bat-El Yoshai, Raquel Benchoam-Ravid, Shai Ashkenazi, Abraham Seidmann

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Arriel BenisFaculty of Industrial Engineering and Technology Management, Holon Institute of Technology, Holon 5810201, Israel.ORCID 0000-0002-9125-8300
Maxim BankerFaculty of Industrial Engineering and Technology Management, Holon Institute of Technology, Holon 5810201, Israel.ORCID 0000-0001-8819-3481
David PinkasovichFaculty of Industrial Engineering and Technology Management, Holon Institute of Technology, Holon 5810201, Israel.ORCID 0000-0003-4228-8236
Mark KirinFaculty of Industrial Engineering and Technology Management, Holon Institute of Technology, Holon 5810201, Israel.ORCID 0000-0002-0524-5088
Bat-El YoshaiFaculty of Industrial Engineering and Technology Management, Holon Institute of Technology, Holon 5810201, Israel.ORCID 0000-0001-5216-9682
Raquel Benchoam-RavidIMA Group Clinic, Rochester, NY 14610, USA.
Shai AshkenaziAdelson School of Medicine, Ariel University, Ariel 4070000, Israel.ORCID 0000-0001-7244-0679
Abraham SeidmannDepartment of Information Systems, Questrom Business School, Boston University, Boston, MA 02215, USA.ORCID 0000-0003-1822-5294
Holon Institute of Technology · ILAriel University · ILBoston University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic challenges healthcare services. Concomitantly, this pandemic had a stimulating effect on technological expansions related to telehealth and telemedicine. We sought to elucidate the principal patients' reasons for using telemedicine during the COVID-19 pandemic and the propensity to use it thereafter. Our primary objective was to identify the reasons of the survey participants' disparate attitudes toward the use of telemedicine. We performed an online, multilingual 30-question survey for 14 days during March-April 2021, focusing on the perception and usage of telemedicine and their intent to use it after the pandemic. We analyzed the data to identify the attributes influencing the intent to use telemedicine and built decision trees to highlight the most important related variables. We examined 473 answers: 272 from Israel, 87 from Uruguay, and 114 worldwide. Most participants were women (64.6%), married (63.8%) with 1-2 children (52.9%), and living in urban areas (84.6%). Only a third of the participants intended to continue using telemedicine after the COVID-19 pandemic. Our main findings are that an expected substitution effect, technical proficiency, reduced queueing times, and peer experience are the four major factors in the overall adoption of telemedicine. Specifically, (1) for most participants, the major factor influencing their telemedicine usage is the implicit expectation that such a visit will be a full substitute for an in-person appointment; (2) another factor affecting telemedicine usage by patients is their overall technical proficiency and comfort level in the use of common web-based tools, such as social media, while seeking relevant medical information; (3) time saving as telemedicine can allow for asynchronous communications, thereby reducing physical travel and queuing times at the clinic; and finally (4) some participants have also indicated that telemedicine seems more attractive to them after watching family and friends (peer experience) use it successfully.

Indexed as

coronavirusCOVID-19eHealthhealth care deliveryhealth servicesinternet usepandemicpatient satisfactionSARS-CoV-2social distancingteleconsultationtelemedicine

Identifiers

PMID34884221
PMCPMC8658517
OpenAlexW3215471305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.